Take Care Before Diving Into The Deep End On Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited (SHSE:600329)

Simply Wall StDec 4 18:48 ET

Tj Darentang USD: Wang Lei succeeds Zhang Mingrui as chairman, the company's development global strategy "will not change" | Express announcement

① Zhang Mingrui has applied to resign from the positions of tj darentang usd chairman, director, and chairman of the Global Strategy Committee due to work-related reasons. ② Wang Lei, the general manager of the company, will take over as chairman, with company officials stating that the enterprise's development strategy "will not change".

cls.cnNov 26 08:20 ET

Express News | Tianjin Pharmaceutical Da Ren Tang Group Corp - Zhang Mingrui Resigns as Chairman

ReutersNov 26 05:10 ET

tj darentang (600329.SH): Elected director Wang Lei as the chairman of the company.

Grainbull November 26th | tj darentang usd (600329.SH) announced that they have received Ms. Zhang Mingrui's written resignation. Due to job changes, Ms. Zhang Mingrui has applied to resign from the positions of company chairman, director, and chairman of the strategic committee. After the resignation, Ms. Zhang Mingrui will no longer hold any position in the company. After the company board of directors' nomination and the nomination committee's review, the meeting approved the proposal to "elect Ms. Wang Lei as the company's chairman." According to the company's articles of association, the company's legal representative will be changed to Ms. Wang Lei.

Gelonghui FinanceNov 26 03:38 ET

tj darentang usd: Planning to sell 13% of the shares of Zhongmei SmithKline, still awaiting approval from the antitrust review | Direct hit on the shareholders' meeting

① Today's tj darentang shareholder meeting approved the proposal to sell a 13% stake in Sino-US Tianjin Schering Pharmaceutical Co., Ltd. (referred to as: Sino-US Schering). The company's chairman, Zhang Mingrui, stated: "Sino-US Schering is an outstanding company, and this stake sale is mainly due to the expiration of the 40-year cooperation period." ② The sale of the stake still requires approval from He Liyang after anti-monopoly review by the State Administration for Market Regulation.

cls.cnNov 22 06:16 ET

We Think Tianjin Pharmaceutical Da Ren Tang Group (SHSE:600329) Can Manage Its Debt With Ease

Simply Wall StNov 12 17:59 ET